Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
EyePoint Pharmaceuticals Inc (EYPT)  
$0.44 0.00 (0.00%) as of 4:30 Tue 12/8


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 143,520,000
Market Cap: 63.51(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.4425 - $0.4425
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   EyePoint Pharmaceuticals is a pharmaceutical company focused on developing and commercializing therapeutics for patients with eye disorders. Co.'s primary product candidate, EYP-19, is a potential sustained delivery intravitreal anti-VEGF treatment targeting wet age-related macular degeneration. YUTIQ 50 (fluocinolone acetonide intravitreal implant) 0.18 mg for intravitreal injection, is for the treatment of non-infectious uveitis affecting the posterior segment of the eye. DEXYCU® (dexamethasone intraocular suspension) 9%, for intraocular administration, is indicated for the treatment of post-operative ocular inflammation.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 1,431,765 4,794,057 4,794,057 4,794,057
Total Buy Value $20,571,167 $89,496,413 $89,496,413 $89,496,413
Total People Bought 1 1 1 1
Total Buy Transactions 2 6 6 6
Total Shares Sold 0 6,161,499 6,722,029 6,722,029
Total Sell Value $0 $121,266,413 $128,353,600 $128,353,600
Total People Sold 0 6 7 7
Total Sell Transactions 0 24 32 32
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 268
  Page 3 of 11  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Jones David Scott SVP & Chief Commercial Officer   •       –      –    2024-01-06 4 OE $0.00 $0 D/D 15,285 42,109     -
   Duker Jay S. President and CEO   •       •      –    2024-01-06 4 D $20.40 $133,171 D/D (6,528) 43,486     -
   Duker Jay S. President and CEO   •       •      –    2024-01-06 4 OE $0.00 $0 D/D 20,793 50,014     -
   Lurker Nancy Executive Vice Chair   •       •      –    2024-01-06 4 D $20.40 $470,077 D/D (23,043) 170,441     -
   Lurker Nancy Executive Vice Chair   •       •      –    2024-01-06 4 OE $0.00 $0 D/D 75,133 193,484     -
   Elston George Chief Financial Officer   •       –      –    2024-01-06 4 D $20.40 $100,184 D/D (4,911) 35,308     -
   Elston George Chief Financial Officer   •       –      –    2024-01-06 4 OE $0.00 $0 D/D 15,285 40,219     -
   Pine Michael Craig Chief Corp Dev.&Strat. Officer   •       –      –    2024-01-06 4 D $20.40 $121,706 D/D (5,966) 13,662     -
   Pine Michael Craig Chief Corp Dev.&Strat. Officer   •       –      –    2024-01-06 4 OE $0.00 $0 D/D 15,285 19,628     -
   Paggiarino Dario A. Chief Medical Officer   •       –      –    2024-01-06 4 D $20.40 $91,535 D/D (4,487) 36,505     -
   Paggiarino Dario A. Chief Medical Officer   •       –      –    2024-01-06 4 OE $0.00 $0 D/D 15,285 40,992     -
   Lurker Nancy Executive Vice Chair   •       •      –    2023-12-28 4/A GA $0.00 $0 I/I 52,208 52,208     -
   Lurker Nancy Executive Vice Chair   •       •      –    2023-12-28 4/A GD $0.00 $0 D/D 52,208 118,351     -
   Paggiarino Dario A. Chief Medical Officer   •       –      –    2023-12-13 4 S $20.00 $29,160 D/D (1,458) 25,707     -
   Paggiarino Dario A. Chief Medical Officer   •       –      –    2023-12-13 4 OE $10.13 $14,770 D/D 1,458 27,165     -
   Cormorant Global Healthcare Master Fund, Lp   •       •       •   2023-12-08 4 B $17.00 $9,999,995 I/I 588,235 6,038,235 0.01     -
   Ocumension Therapeutics Director   –       •      –    2023-12-06 4 S $18.41 $4,901,515 D/D (266,242) 2,010,721     -
   Liu Ye   –       •      –    2023-12-06 4 S $18.41 $4,901,515 I/I (266,242) 2,010,721     -
   Ocumension Therapeutics Director   –       •      –    2023-12-05 4 S $19.91 $14,609,122 D/D (733,758) 2,276,963     -
   Liu Ye   –       •      –    2023-12-05 4 S $19.91 $14,609,122 I/I (733,758) 2,276,963     -
   Pine Michael Craig Chief Corp Dev.&Strat. Officer   •       –      –    2023-12-04 4/A S $20.79 $1,010,790 D/D (46,000) 4,343     -
   Chen Bihua   –       –       •   2023-12-04 3 IO $0.00 $0 I/I 0 3,530,943     -
   Cormorant Global Healthcare Master Fund, Lp   •       •       •   2023-12-04 4 B $18.80 $41,874,151 I/I 1,919,057 5,450,000 0.01     -
   Pine Michael Craig Chief Corp Dev.&Strat. Officer   •       –      –    2023-12-04 4 S $22.00 $990,000 D/D (45,000) 5,343     -
   Pine Michael Craig Chief Corp Dev.&Strat. Officer   •       –      –    2023-12-04 4 OE $12.62 $567,900 D/D 45,000 50,343     -
  268 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 3 of 11
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us